Categories: Uncategorized

India’s homegrown COVAXIN has drawn global attention

The indigenous vaccine of India has drawn global attention says ICMR that the Indian vaccine against #Covid-19, Covaxin, has drawn global attention.

“India’s indigenous vaccine against Covid19 Covaxine – a product of ICMR-Bharat Biotech collaboration, achieves the remarkable feat. Data generated from within India underlines impressive safety and immunogenicity profile of Covaxine and sparks Lancet’s interest in publishing them.” Tweets ICMR

The ICMR also said,” Encouraging Phase 1 and Phase 2 Covaxin trial results have paved the path for Phase 3 clinical trials in India, which is currently ongoing at 22 sites.”

Medically Speaking Team

Recent Posts

India’s Cancer Care Revolution: What to Expect by 2025

In recent years, India has made significant strides in the fight against cancer, with an…

2 days ago

Boost Brain Health with the MIND Diet: A Powerful Tool Against Cognitive Decline

As we age, our cognitive abilities naturally decline, but diet has emerged as a key…

2 days ago

AI in Healthcare: Revolutionizing Personalised Medicine in Andhra Pradesh

In a significant move toward revolutionizing patient care, a panel discussion on Artificial Intelligence (AI)-based…

2 days ago

AI Revolutionizes Breast Cancer Detection with 17% Accuracy Boost

Breast cancer remains one of the leading causes of cancer-related deaths among women worldwide. Early…

2 days ago

Living Near Airports: Is Your Heart at Risk?

Airport Proximity: Can living near an airport increase your risk of a heart attack? A…

2 days ago

The Silent Epidemic: Superbugs Push Indian Families into Debt

Antimicrobial resistance (AMR), the ability of bacteria, fungi, and parasites to resist the effects of…

3 days ago